Management of pregnancies with confirmed cytomegalovirus fetal infection

G Benoist, M Leruez-Ville, JF Magny… - Fetal diagnosis and …, 2013 - karger.com
Systematic screening for cytomegalovirus (CMV) maternal infection is not recommended in
most countries. Nevertheless, primary CMV infection will occur in around 1% of women. The …

Prevalence, timing of diagnosis and mortality of newborns with congenital heart defects: a population-based study

B Khoshnood, N Lelong, L Houyel, AC Thieulin… - Heart, 2012 - heart.bmj.com
Objective To assess the prevalence, timing of diagnosis and infant mortality of congenital
heart defects (CHD) with population-based data and using a classification that allows …

[HTML][HTML] In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study

M Leruez-Ville, I Ghout, L Bussières… - American journal of …, 2016 - Elsevier
Background Congenital infection with human cytomegalovirus is a major cause of morbidity
and mortality. A randomized controlled trial showed that high-dosage valacyclovir prevents …

[HTML][HTML] Treatment of homozygous protein C deficiency and neonatal purpura fulminans with a purified protein C concentrate

M Dreyfus, JF Magny, F Bridey… - … England Journal of …, 1991 - Mass Medical Soc
PROTEIN C is a vitamin K—dependent glycoprotein circulating in plasma as an inactive
zymogen. 1 It is converted to the serine protease—activated protein C, a natural …

Both relative insulin resistance and defective islet β-cell processing of proinsulin are responsible for transient hyperglycemia in extremely preterm infants

D Mitanchez-Mokhtari, N Lahlou, F Kieffer… - …, 2004 - publications.aap.org
Objective. Many extremely preterm infants develop hyperglycemia in the first week of life
during continuous glucose infusion. The objective of this study was to determine whether …

Sequelae of congenital cytomegalovirus following maternal primary infections are limited to those acquired in the first trimester of pregnancy

V Faure-Bardon, JF Magny, M Parodi… - Clinical infectious …, 2019 - academic.oup.com
Background The known relationship between the gestational age at maternal primary
infection an the outcome of congenital CMV is based on small, retrospective studies …

Risk factors for congenital cytomegalovirus infection following primary and nonprimary maternal infection: a prospective neonatal screening study using polymerase …

M Leruez-Ville, JF Magny, S Couderc… - Clinical Infectious …, 2017 - academic.oup.com
Background. The design of diagnostic and preventive strategies have been prevented by
gaps in knowledge of the epidemiology of congenital cytomegalovirus (cCMV) with the type …

Prospective randomized multicenter comparison of high-frequency oscillatory ventilation and conventional ventilation in preterm infants of less than 30 weeks with …

G Moriette, J Paris-Llado, H Walti, B Escande… - …, 2001 - publications.aap.org
Background. Early use of high-frequency ventilation and exogenous surfactant is proposed
as the optimal mode of ventilatory support in infants with respiratory distress syndrome. In …

Feasibility of predicting the outcome of fetal infection with cytomegalovirus at the time of prenatal diagnosis

M Leruez-Ville, J Stirnemann, Y Sellier… - American journal of …, 2016 - Elsevier
Background Congenital cytomegalovirus infection occurs in 0.7% of live births with 15-20%
of infected children developing long-term disability including hearing loss and cognitive …

Population pharmacokinetics of midazolam in neonates

P Burtin, E Jacqz‐Aigrain, P Girard… - Clinical …, 1994 - Wiley Online Library
Objective To describe the pharmacokinetics of midazolam, a water‐soluble benzodiazepine
with a short half‐life, in critically ill neonates. Hypothesis Midazolam clearance is reduced in …